top of page
API | Intermediate | CAS Number |
---|---|---|
Brivaracetam | (+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one | 63095-51-2 |
Brivaracetam | (+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one | 63095-51-2 |
Brexpiprazole | 913611-97-9 | |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium(2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine(R)-2-hydroxy-2- phenylacetate (1:1) | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine(R)-2-hydroxy-2- phenylacetate (1:1) | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride(1:1) | 1156491-10-9 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride(1:1) | 1156491-10-9 |
Ticagrelor | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
Ticagrelor | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanaMine hydrochloride | 1402222-66-5 |
Ticagrelor | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine (R)-2-hydroxy-2-phenylacetate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-dihydroxybutanedioate | 220352-39-6 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanami nium
(2R}-hydroxy(phenyl )ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanami ne Hydrochloride | 1402222-66-5 |
Ticagrelor | (1R,2S)-2-(3,4-
difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
Ticagrelor | (1R,2S)-2-(3,4-
difluorophenyl)cyclopropanamine (2R,3R)- 2,3-dihydroxysuccinate | 220352-39-6 |
Ticagrelor | (1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium | 376608-71-8 |
Ticagrelor | (1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)- (carboxylato(phenyl) methyl)holmium | 376608-71-8 |
Lapatinib | (1R,2R)-(-)-1,2-diaminocyclohexane acid | 20439-47-8 |
Eribulin, Mesylate | (1-Bromovinyl) trimethylsilane | 13683-41-5 |
Brivaracetam | (+)-R-4-Propyl-dihydrofuran-2(3H)-one | 63095-51-2 |
Brivaracetam | (+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one | 63095-51-2 |
Brivaracetam | (+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one | 63095-51-2 |
Dapoxetine | ((S)-3-Phenyl-beta-alannol HCl | 936499-93-3 |
Pitavastatin | ((2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)diphenylphosphine oxide | 146578-99-6 |
Tezacaftor | (((2,2-Dimethyl-3-butyn-1-yl)oxy) methyl) benzene | 1092536-54-3 |
Apixaban | 503612-47-3 | |
Brexpiprazole | 913611-97-9 | |
Cabazitaxel | 183133-94-0 | |
Cabazitaxel | 149198-47-0 | |
Febuxostat | 144060-53-7 | |
Isavuconazole | 1-(((2R,3S)-2-(2,5-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole | 241479-73-2 |
Liraglutide | 1491158-62-3 | |
Liraglutide | 294855-91-7 | |
Liraglutide | 536721-25-2 | |
Liraglutide | 14464-31-4 | |
Macitentan | 441798-33-0 | |
Macitentan | 149506-35-4 | |
Macitentan | 706811-25-8 | |
Nintedanib | 2653-16-9 | |
Perampanel | 16179-97-8 | |
Perampanel | 18698-99-2 | |
Ticagrelor | 1006614-49-8 | |
Ticagrelor | 60410-16-4 | |
Ticagrelor | 633312-86-4 | |
Brivaracetam | (+)-R-4-Propyl-dihydrofuran-2(3H)-one | 63095-51-2 |
Tafluprost | (3aR,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-Cyclopenta[b]furan-2-one | 209861-00-7 |
Tafluprost | (3aR,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-Cyclopenta[b]furan-2-one | 209861-00-7 |
Tafluprost | (3aR,4R,5R,6aS)-5-((1-(l1-boranyl)-2l1-diphosphanyl)oxy)-4-((E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one | none |
Tafluprost | (3aR,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-5-hydroxyhexahydro-2H-cyclopenta[b]furan-2-one | 209861-01-8 |
Maraviroc | (3-exo)-8-(Phenylmethyl)-8-azabicyclo[3.2.1]octan-3-amine fumarate salt | 76272-36-1 |
Maraviroc | (3-exo)-3-[3-Methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octane | 423165-07-5 |
Maraviroc | (3-exo)-3-[3-Methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-(phenylmethyl)-8-azabicyclo[3.2.1]octane | 423165-13-3 |
Sitagliptin | (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine | 767340-03-4 |
Sitagliptin | (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6- dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)- yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine. | 767340-03-4 |
Saxagliptin | (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid | 361442-00-4 |
Vildagliptin | (2S)-1-chloroacetyl-2-pyrrolidine carbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
Isavuconazole | (2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanethioamide | 368421-58-3 |
Tezacaftor | (2R)-1-{5-Amino-2-[1-(benzyloxy)-2-methyl-2-propanyl]-6-fluoro-1H -indol-1-yl}-3-(benzyloxy)-2-propanol | 1294504-67-8 |
Tezacaftor | (2R)-1-{5-Amino-2-[1-(benzyloxy)-2-methyl-2-propanyl]-6-fluoro-1H -indol-1-yl}-3-(benzyloxy)-2-propanol | 1294504-67-8 |
Pitavastatin | (2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol | 121660-11-5 |
Pazopanib | (2-Chloro-pyrimidin-4-yl)-(2,3-dimethyl-2H-indazol-6-yl)-methyl-amine | 444731-75-3 |
Dronedarone | (2-butyl-5-nitro-3-benzofuranyl)(4-hydroxyphenyl)-Methanone | 141645-16-1 |
Peramivir | (1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-Carboxylic Acid Methyl Ester | 229613-93-8 |
Peramivir | (1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]amino]- 2-Cyclopentene-1-carboxylic acid Methyl ester | 229613-93-8 |
Peramivir | (1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester | 229613-93-8 |
Peramivir | (1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2- Cyclopentene-1-carboxylic acid Methyl ester | 229613-93-8 |
Saxagliptin | (1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate | 361440-67-7 |
Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 |
Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 |
Brivaracetam | (S)-2-Aminobutanamide hydrochloride | 7682-20-4 |
Brivaracetam | (R)-Dihydro-4-propyl-2(3H)-furanone | 63095-51-2 |
Brivaracetam | (R)-4-propyldihydrofuran-2-one | 63095-51-2 |
Brivaracetam | (R)-4-Propyldihydrofuran-2(3H)-one | 63095-51-2 |
Brivaracetam | (R)-4-propyldihydrofuran-2(3H)- one | 63095-51-2 |
Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxy lic acid tert-butyl ester | 361440-67-7 |
Saxagliptin | (1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3.1.0)hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 |
Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2- azabicyclo[3.1.0]hexane-2- carboxylic acid tert-butyl ester | 361440-67-7 |
Saxagliptin | (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide monomethanesulfonate | 709031-45-8 |
Saxagliptin | (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate | 709031-45-8 |
Saxagliptin | (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride | 709031-39-0 |
Saxagliptin | (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3- carboxamide methanesulfonate | 709031-45-8 |
Peramivir | (1S,2S,3S,4R)-Methyl 3-((R)-1-Amino-2-Ethylbutyl)-4-(Tert-Butoxycarbonylamino)-2-Hydroxycyclopentanecarboxylate | 316173-29-2 |
Saxagliptin | (1S, 3S, 5S)-3-(aminocarbonyl)-2-azabicyclo(3.1.0)hexane-2-carboxylic acidtert-butyl ester | 361440-67-7 |
Peramivir | (1R,4S)-Methyl 4-aMinocyclopent-2-enecarboxyla | 419563-22-7 |
Oclacitinib | (1r,4r)-4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylic acid | 53292-89-0 |
Ticagrelor | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium-(2R)-Hydroxy (phenyl)ethanoate | 376608-71-8 |
Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium(2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
Rivaroxaban | (S)-(+)-Glycidyl PhthaliMide | 161596-47-0 |
Rivaroxaban | (S)-(+)-Glycidyl phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-glycidyl phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-glycidyl phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Tezacaftor, Levoketoconazole | (S)-(+)-2,2-Dimethyl-1,3-Dioxolan-4-yl Methyl P-Toluene Sulfonate | 23735-43-5 |
Rivaroxaban | (S)(+)-N-(2, 3-Epoxypropyl)phthalimide | 161596-47-0 |
Rivaroxaban | (S) – Epichlorohydrin | 67843-74-7 |
Lacosamide | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate | 880468-89-3 |
Sitagliptin | (R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl) butanoic acid | 486460-00-8 |
Eribulin, Mesylate | (R)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl) 6-methylphenyl)methane sulfonamide | 871360-40-6 |
Brivaracetam | (R)-Dihydro-4-propyl-2(3H)-furanone | 63095-51-2 |
Indacaterol | (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one | 530084-79-8 |
Brivaracetam | (R)-4-propyldihydrofuran-2-one | 63095-51-2 |
Brivaracetam | (R)-4-Propyldihydrofuran-2(3H)-one | 63095-51-2 |
Brivaracetam | (R)-4-propyldihydrofuran-2(3H)-one | 63095-51-2 |
Brivaracetam | (R)-4-propyldihydrofuran-2(3H)- one | 63095-51-2 |
Brivaracetam | (R)-4-propyldihydrofuran- 2(3H)-one | 63095-51-2 |
Rivaroxaban | (R)-4-[4-[(3-Chloro-2-hydroxypropyl)amino]phenyl]morpholin-3-one | 1252018-10-2 |
Tezacaftor | (R)-4-((3-benzyloxy)-2-hydroxypropyl) amino)-5-bromo-2- fluorobenzenaminium-4-methylbenzenesulfonate | 1294504-64-5 |
Tezacaftor | (R)-4-((3-(benzyloxy)-2-Hydroxypropyl)
amina)-5-bromo-2-fluorobenzenaminium 4-
methyl benzenesulfonate | 1294504-64-5 |
Tezacaftor | (R)-1-[5-Amino-2-(2-benzyloxy-1,1-dimethyl-ethyl)-6- fluoro-indol-1-yl]-3-benzyloxy-propan-2-ol | 1294504-67-8 |
Rivaroxaban | (R)-(-)-Glycidyl Phthalimide | 181140-34-1 |
Eribulin | (R)-(-)-3-Hydroxy-2-Methylpropionic Acid Methyl Ester | 72657-23-9 |
Empagliflozin, Fosamprenavir, Afatinib | (R)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
Dasatinib | (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide | 863127-76-8 |
Dasatinib | (E) -N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide | 863127-76-8 |
Ticagrelor | (aR)-a-Hydroxy-benzeneacetic acid compd. with (1R,2S)-2-(3,4- difluorophenyl) cyclopropanamine (1:1) | 376608-71-8 |
Saxagliptin | (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid | 361442-00-4 |
Sacubitril, Valsartan | (alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester calcium salt (2:1) | 1369773-39-6 |
Lapatinib | (5-formylfuran-2-yl)boronic acid | 27329-70-0 |
Pitavastatin | (4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-
quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester | 147489-06-3 |
Empagliflozin, Fosamprenavir, Afatinib | (3S)-Tetrahydro-3-Furanyl 4-Methylbenzenesulfonate | 112052-11-6 |
Nintedanib | (3e)-2,3-dihydro-3-(methoxyphenylmethylene)-2-oxo-1h-indole-6-carboxylicacid methyl ester | 1168150-46-6 |
Nintedanib | (3e)-2,3-dihydro-3-(methoxyphenylmethylene)-2-oxo-1h-indole-6-carboxylic acid methyl ester | 1168150-46-6 |
Ticagrelor | (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol | 155899-66-4 |
Ticagrelor | (3aR,4S,6R,6aS)-6-Amino-2,2-dimethyl-tetrahydro-3aHcyclopenta[d][1,3]dioxol-4-ol | 155899-66-4 |
Ticagrelor | (3aR,4S,6R,6aS)-6-Amino-2,2-dimethyl-tetrahydro-3aHcyclopenta[d][1,3]dioxol-4-ol | 155899-66-4 |
Peramivir | (3aR,4R,6S,6aS)-4-(tert-butoxycarbonylaMino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylic acid | 316173-28-1 |
Apixaban | 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone | 1267610-26-3 |
Apixaban | 1-(4-Aminophenyl)-3-(morpholin-4-yl)-5,6- dihydropyridin-2(1H)-one | 1267610-26-3 |
Tolvaptan | 1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | 137977-97-0 |
Nilotinib | 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one | 55314-16-4 |
Nilotinib | 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one | 55314-16-4 |
Sitagliptin | 1-(3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-a]Pyrazin-7(8H)-yl)-4-(2,4,5-Trifluorophenyl)Butane-1,3-Dione | 764667-65-4 |
Eltrombopag | 1-(3,4-Dimethylphenyl)-3-Methyl-3-Pyrazolin-5-One | 18048-64-1 |
Eltrombopag | 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one | 376592-93-7 |
Ranolazine | 1-(2-Methoxyphenoxy)-2,3-epoxypropane | 2210-74-4 |
Bilastine | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzol[d]imidazole | 110963-63-8 |
Bilastine | 1-(2-Ethoxy ethyl)-2-(Piperidin-4-yl)-1H-Benzo (d) Imidazole Sesqui Hydrate | 110963-63-8 |
Dexmedetomidine | 1-(2,3-Dimethylphenyl)ethyl chloride | 60907-88-2 |
Brexpiprazole | 1-(1-benzothiophen-4-yl)piperazinehydrochloride | 913614-18-3 |
Nintedanib | 1,3-Dimethyl 2-[4-(Methoxycarbonyl)-2-Nitrophenyl]Propanedioate (Under Development) | 1160293-27-5 |
Fesoterodine | 1 rac 5-Hydroxymethyl Tolterodine | 200801-70-3 |
Nintedanib | 1 Methyl 2-oxoindole-6-carboxylate | 14192-26-8 |
Eltrombopag | 1 2-bromo-6-nitrophenol | 13073-25-1 |
Ticagrelor | 1 ( 1 R t r a n s ) - 2 - ( 3 , 4 - d i f l u o ro p h e n y l ) c y c l o p ro pa n e a m i n e hydrochloride | 1156491-10-9 |
Nintedanib | (Z)-Methyl 1-(2-Chloroacetyl)-3-(Methoxy(Phenyl)Methylene)-2-Oxoindoline-6-Carboxylate (Under Development) | 1160293-24-2 |
Apixaban | (Z)-Ethyl 2-chloro-2-(2-(4- methoxyphenyl)hydrazono)acetate | 27143-07-3 |
Empagliflozin, Afatinib | (S)-tetrahydrofuran-3-ol | 86087-23-2 |
Trabectedin | (S)-tert-butyl 2-(((allyloxy)carbonyl)amino)-3-(3,5-bis((tert-butyldimethylsilyl)oxy)-4-methoxyphenyl)propanoate | 200132-74-7 |
Eribulin, Mesylate | (S)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl) methanesulfonamide(EBH) | 480444-15-3 |
Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl | 898543-06-1 |
Brexpiprazole, Dasatinib | 1-BOC PIPERAZINE | 57260-71-6 |
Brexpiprazole | 1-benzo[b]thien-4-yl-piperazine hydrochloride | 913614-18-3 |
Brexpiprazole | 1-benzo[b]thien-4-yl-piperazine hydrochloride | 913614-18-3 |
Brexpiprazole | 1-Benzo[b]thien-4-yl-piperazine hydrochloride | 913614-18-3 |
Brexpiprazole | 1-benzo[b]thien-4-yl-piperazine hydrochloride | 913614-18-3 |
Brexpiprazole | 1-Benzo[b] thien-4-yl-piperzine hydrochloride | 913614-18-3 |
Bilastine | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzol[d]imidazole | 110963-63-8 |
Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 |
Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 |
Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one HCl | 898543-06-1 |
Rivaroxaban | (S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one | 446292-10-0 |
Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3- yl)phenyl)morpholin-3-one.HCl | 898543-06-1 |
Empagliflozin, Fosamprenavir, Amprenavir, Afatinib | (S)-3-Hydroxy Tetrahydrofuran | 86087-23-2 |
Dapoxetine | (S)-3-Amino-3-phenyl-1-propanol hydrochloride | 936499-93-3 |
Brivaracetam | (S)-2-Aminobutanamide hydrochloride | 7682-20-4 |
Tezacaftor | (S)-2,2-Dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate | 23735-43-5 |
Vildagliptin, Anagliptin | (S)-1-(2’-Chloroacetyl)pyrrolidine-2-carbonitrile | 207557-35-5 |
Vildagliptin | (S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide | 214398-99-9 |
Vildagliptin | (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile | 207557-35-5 |
Vildagliptin | (S)-1-(2-chloroacetyl) pyrrolidine-2-carbonitrile | 207557-35-5 |
Rivaroxaban | (S)-(+)-N-(2,3-epoxypropyl)phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 |
Rivaroxaban | (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 |
bottom of page